Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Yavo, William ^a,e   Faye, Babacar ^b   Kuete, Thomas ^c   Djohan, Vincent ^a   Oga, Serge A ^a   Kassi, Richard R ^d   Diatta, Mariama ^b   Ama, Moor V ^c   Tine, Roger ^b   Ndiaye, Jean Louis ^b   Evi, Jean Bedel ^a   Same Ekobo, Albert ^c,f   Faye, Oumar ^b   Koné, Moussa ^a  

^a Faculty of Pharmaceutical and Biological Sciences   (Côte d’Ivoire)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c Faculty of Medecine and Pharmaceutical Sciences of Douala   (Cameroon)

^d Projet RETROCI   (Côte d’Ivoire)

^e National Institute of Public Health (INSP)   (Côte d’Ivoire)

^f University Hospitals   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE; DUOCOTECXIN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PIPERAQUINE; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CAMEROON; CHILD; CONTROLLED STUDY; COTE D'IVOIRE; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FACE EDEMA; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECRUDESCENCE; REINFECTION; SCHOOL CHILD; SENEGAL; SOMNOLENCE; TREATMENT OUTCOME; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; CAMEROON; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; QUINOLINES; SENEGAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960562239     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-198     Document Type: Article

References (26)

1. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA, Malar J 2008 7 237 10.1186/1475-2875-7-237 19017387
2. World Health Organization, World malaria report 2008 Geneva 2008
3. Artesunate combinations for treatment of malaria: meta-analysis. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, Lancet 2004 363 9 17 14723987 (Pubitemid 38076919)
4. How much fat is necessary to optimize lumefantrine oral bioavailability? Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F, Trop Med Int Health 2007 12 195 200 10.1111/j.1365-3156.2006.01784.x 17300625
5. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159 10.1086/503051 16544256
6. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Broek I van den, Kitz C, Al Attas S, Libama F, Balasegaram M, Guthmann JP, Malar J 2006 5 113 10.1186/1475-2875-5-113 17125496 (Pubitemid 44915803)
7. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Denis MB, Davis TM, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Y, Lim C, Socheat D, Clin Infect Dis 2002 35 1469 1476 10.1086/344647 12471565 (Pubitemid 36020689)
8. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (ArtekinH) in Cambodian children and adults with malaria. Karunajeewa H, Lim C, Hung TY, Ilett KF, Denis MB, Socheat D, Davis TM, Br J Clin Pharmacol 2004 57 93 99 14678346 (Pubitemid 38067955)
9. Dihydroartemisinin-piperaquine against multidrug resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J, Lancet 2004 363 18 22 10.1016/S0140-6736(03)15163-X 14723988 (Pubitemid 38076920)
10. An open, randomized comparison of artesunate plus mefloquine vs dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Mayxay M, Thongpraseuth V, Khanthavong M, Lindegårdh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K, White NJ, Newton PN, Trop Med Int Health 2006 11 1157 1165 10.1111/j.1365-3156.2006.01671.x 16903879 (Pubitemid 44125705)
11. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open label randomized comparison. Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, Stepniewska K, White NJ, Lancet 2006 367 2075 2085 10.1016/S0140-6736(06)68931-9 16798391 (Pubitemid 43949291)
12. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. Janssens B, van Herp M, Goubert L, Chan S, Uong S, Nong S, Socheat D, Brockman A, Ashley EA, Van Damme W, Trop Med Int Health 2007 12 251 259 10.1111/j.1365-3156.2006.01786.x 17300633
13. Supervised versus unsupervised intake of six-dose artemetherlumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP, Lancet 2005 365 1467 1473 10.1016/S0140-6736(05) 66416-1 15850630 (Pubitemid 40591691)
14. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem ) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Fanello CI, Karema C, van Doren W, van Overmeir C, Ngamije D, D'Alessandro U, Trans R Soc Trop Med Hyg 2007 101 344 350 10.1016/j.trstmh.2006.06.010 17005222 (Pubitemid 46196260)
15. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria Geneva 2003
16. A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children. Faye B, Ndiaye JL, Tine R, Sylla K, Gueye A, Lo A, Gaye O, Am J Trop Med Hyg 2010 82 140 144 10.4269/ajtmh.2010.09-0265 20065010
17. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Dicko A, Sagara I, Djimdé AA, Touré SO, Traore M, Dama S, Diallo AI, Barry A, Dicko M, Coulibaly OM, Rogier C, de Sousa A, Doumbo OK, Malar J 2010 9 9 10.1186/1475-2875-9-9 20064223
18. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Ashley EA, McGready R, Hutagalung R, Phaiphun L, Slight T, Proux S, Thwai KL, Barends M, Looareesuwan S, White NJ, Nosten F, Clin Infect Dis 2005 41 425 432 10.1086/432011 16028147 (Pubitemid 41099632)
19. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, PLoS Clin Trials 2007 2 20 10.1371/journal.pctr. 0020020 (Pubitemid 46860146)
20. ® ) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Karema C, Fanello CI, van Overmeir C, van Geertruyden J-P, van Doren W, Ngamije D, D'Alessandro U, Trans R Soc Trop Med Hyg 2006 101 1105 1111 (Pubitemid 44464010)
21. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Osorio L, Gonzalez IJ, Olliaro P, Taylor WR, Malar J 2007 6 25 10.1186/1475-2875-6-25 17328806 (Pubitemid 46437047)
22. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung MR, Laihad F, EbsworthP PE, Anstey MN, Tjitra E, Price NR, Lancet 2007 369 757 765 10.1016/S0140-6736(07)60160-3 17336652 (Pubitemid 46335820)
23. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386
24. Randomized, controlled dose-optimization studies of dihydroartemisinin- piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ, J Infect Dis 2004 190 1773 1782 10.1086/425015 15499533 (Pubitemid 39487822)
25. Efficacy and safety of dihydroartemisinin-piperaquine. Myint HY, Ashley EA, Day NP, Nosten F, White NJ, Trans R Soc Trop Med Hyg 2007 101 858 866 10.1016/j.trstmh.2007.05.018 17659311 (Pubitemid 47091464)
26. Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China. Wang SQ, Christophel E, Lin SG, Meng F, Hu XM, Wang GZ, Liu J, Zeng LH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2008 26 50 52 18637586